Loading...
OTCM
MDCE
Market cap1mUSD
Oct 07, Last price  
0.00USD
1D
11.11%
1Q
66.67%
Jan 2017
400.00%
IPO
-28.57%
Name

Medical Care Technologies Inc

Chart & Performance

D1W1MN
No data to show
P/E
12.25
P/S
2.81
EPS
0.00
Div Yield, %
Shrs. gr., 5y
2.26%
Rev. gr., 5y
%
Revenues
656k
-10.32%
00000000003,469,685731,971656,402
Net income
150k
P
-37,543-55,742-85,121-1,940,207-1,923,887-2,763,311-4,358,7010001,099,465-387,506150,379
CFO
-616k
L
-32,969-21,050-82,050-134,135-371,920-245,142000139,54729,912-616,079

Profile

Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other merchandise, including over-the-counter medicines, herbal products, personal care products, and family care products. It serves retail pharmacies, pharmaceutical companies, hospitals, physicians' office practices, and consumers; and industrial and food microbiology laboratories. The company offers its products through its pediatric health and wellness centers, Website, and retail pharmacies, as well as through sales and distribution channels, and directly to end-users through independent sales representatives. Medical Care Technologies Inc. was founded in 2007 and is headquartered in Beijing, China.
IPO date
Jul 23, 2012
Employees
Domiciled in
HK
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
656
-10.32%
732
-78.90%
3,470
 
Cost of revenue
335
1,113
2,139
Unusual Expense (Income)
NOPBT
322
(381)
1,330
NOPBT Margin
49.03%
38.34%
Operating Taxes
(228)
Tax Rate
NOPAT
322
(381)
1,559
Net income
150
-138.81%
(388)
-135.24%
1,099
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
68
39
28
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
15
4
16
Cash flow
Cash from operating activities
(616)
30
140
CAPEX
Cash from investing activities
Cash from financing activities
633
(6)
(128)
FCF
(539)
19
621
Balance
Cash
52
35
12
Long term investments
Excess cash
20
Stockholders' equity
(10,627)
(10,778)
(10,391)
Invested Capital
12,079
11,351
11,340
ROIC
2.75%
13.65%
ROCE
22.18%
140.12%
EV
Common stock shares outstanding
3,309,575
3,209,575
3,209,575
Price
0.00
-7.50%
0.00
-28.57%
0.00
-82.77%
Market cap
6,123
-4.62%
6,419
-28.57%
8,987
-81.31%
EV
6,138
6,423
9,003
EBITDA
322
(381)
1,330
EV/EBITDA
19.07
6.77
Interest
3
6
Interest/NOPBT
0.81%